share_log

Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

万基遗传 | 8-K:Myriad Genetics公布了强劲的2024年第二季度财务业绩,包括收入同比增长15%;将2024年的财务指导和长期收入增长目标提高至12%
美股SEC公告 ·  2024/08/07 04:18
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息